CORC  > 四川大学
HIF-1 alpha and VEGF levels for monitoring hepatocellular carcinoma treatment response to transcatheter arterial chemoembolization
Liu, K; Yang, L; Zhang, XM; Zhou, Y; Zhu, T; Miao, ND; Ren, YJ; Xu, H; Min, XL; Peng, J
刊名TRANSLATIONAL CANCER RESEARCH
2017
卷号Vol.6 No.6页码:1043-1049
关键词Liver cancer chemoembolization angiogenesis treatment response
ISSN号2218-676X
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/1840491
专题四川大学
作者单位1.Yanan Univ, Xianyang Hosp, Dept Pain Management, Xianyang 712000, Peoples R China
2.North Sichuan Med Coll, Dept Prevent Med, Nanchong 637000, Peoples R China
3.North Sichuan Med Coll, Affiliated Hosp, Sichuan Key Lab Med Imaging, Dept Radiol, Nanchong 637000, Peoples R China
推荐引用方式
GB/T 7714
Liu, K,Yang, L,Zhang, XM,et al. HIF-1 alpha and VEGF levels for monitoring hepatocellular carcinoma treatment response to transcatheter arterial chemoembolization[J]. TRANSLATIONAL CANCER RESEARCH,2017,Vol.6 No.6:1043-1049.
APA Liu, K.,Yang, L.,Zhang, XM.,Zhou, Y.,Zhu, T.,...&Peng, J.(2017).HIF-1 alpha and VEGF levels for monitoring hepatocellular carcinoma treatment response to transcatheter arterial chemoembolization.TRANSLATIONAL CANCER RESEARCH,Vol.6 No.6,1043-1049.
MLA Liu, K,et al."HIF-1 alpha and VEGF levels for monitoring hepatocellular carcinoma treatment response to transcatheter arterial chemoembolization".TRANSLATIONAL CANCER RESEARCH Vol.6 No.6(2017):1043-1049.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace